Abbvie Inc Revenue per Employee (ABBV), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Abbvie Inc   (NYSE: ABBV)
 

Abbvie Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 10.32% in the third quarter 2026, year on year to cumulative value of $66,014 million, Abbvie Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,158,140, this marks a new company high.
Within the Healthcare sector Employees of 72 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 807, from total ranking in previous quarter at 1001. Abbvie Inc has 57,000 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABBV Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 10.32 % 10.16 % 12.43 % 10.04 % 9.1 %
Sales per Employee (TTM) $ 1,158,140 1,129,579 1,102,088 1,072,982 1,046,386
ABBV's Total Ranking # 807 # 1001 # 834 # 839 # 864
Seq. Revenue Change 2.44 % 13.25 % -9.72 % 5.34 % 2.29 %

ABBV Company Profile >> Back to ABBV Efficiency Comparisons >> Compare ABBV Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 50
Healthcare Sector # 73
Overall Market # 807

Revenue per Employee Statistics
High Average Low
$ 1,158,140 $ 678,026 $ 322,456
(Sep 30 2026)   (Dec. 31. 2012)



Financial Statements
Abbvie Inc 's Revenue MRQ $ 17,404 Millions Visit ABBV's Income Statement
Abbvie Inc 's Revenues TTM $ 66,014 Millions Visit ABBV's aggregate revenue growth
What are ABBV's Sales? Visit ABBV's Sales by Segment




Other Ratios
Abbvie Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ABBV's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ABBV's Competitors
Revenue per Employee for ABBV's Suppliers
Revenue per Employee for ABBV's Customers

You may also want to know
ABBV's Sales Growth Rates ABBV's Pe Price to earnings ratio ABBV's Receivables Turnover Ratio ABBV's Stock Quote
ABBV's Net Income Growth Rates ABBV's Ps Price to Sales ratio ABBV's Sales per Employee ABBV's Asset Turnover Ratio
ABBV's Net Margin ABBV's Pb Price to Book ratio ABBV's Financial Strength Ratios ABBV's Dividend Payout Ratio
Date modified: 2026-11-04T15:04:13+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Alnylam Pharmaceuticals Inc   2,005,296.80 $ 5,013.242  Million 2,500 
Neurocrine Biosciences Inc   1,850,850.00 $ 3,701.700  Million 2,000 
Tarsus Pharmaceuticals Inc   1,843,791.89 $ 682.203  Million 370 
Gilead Sciences Inc   1,822,823.53 $ 30,988.000  Million 17,000 
Mirum Pharmaceuticals Inc   1,803,166.67 $ 670.778  Million 372 
Eli Lilly And Company  1,729,240.00 $ 86,462.000  Million 50,000 
Alector Inc   1,684,165.05 $ 173.469  Million 103 
Rigel Pharmaceuticals Inc  1,656,396.55 $ 288.213  Million 174 
Jazz Pharmaceuticals Plc  1,632,569.55 $ 4,718.126  Million 2,890 
Krystal Biotech Inc   1,593,305.08 $ 470.025  Million 295 
Madrigal Pharmaceuticals Inc   1,560,590.16 $ 1,427.940  Million 915 
Bristol myers Squibb Company  1,539,476.92 $ 50,033.000  Million 32,500 
Acadia Pharmaceuticals Inc   1,506,642.86 $ 1,202.301  Million 798 
Indivior Pharmaceuticals Inc   1,376,000.00 $ 1,376.000  Million 1,000 
Biogen Inc   1,372,973.33 $ 10,297.300  Million 7,500 
Supernus Pharmaceuticals inc   1,326,849.69 $ 865.106  Million 652 
Corcept Therapeutics Inc  1,320,064.38 $ 963.647  Million 730 
Travere Therapeutics Inc   1,309,927.57 $ 651.034  Million 497 
Lantheus Holdings Inc   1,309,212.07 $ 1,561.890  Million 1,193 
Ptc Therapeutics inc   1,166,048.44 $ 1,155.554  Million 991 
Abbvie Inc   1,158,140.35 $ 66,014.000  Million 57,000 
Biomarin Pharmaceutical Inc  1,134,780.19 $ 3,655.127  Million 3,221 
Bridgebio Pharma Inc   1,126,984.51 $ 945.540  Million 839 
Arvinas Inc   1,119,105.69 $ 275.300  Million 246 
Regeneron Pharmaceuticals Inc   1,096,443.87 $ 16,896.200  Million 15,410 
Ani Pharmaceuticals Inc  1,073,549.48 $ 1,041.343  Million 970 
Verastem Inc   983,294.12 $ 100.296  Million 102 
Syndax Pharmaceuticals Inc   971,244.97 $ 289.431  Million 298 
Ardelyx inc   957,505.11 $ 468.220  Million 489 
Axsome Therapeutics Inc   935,424.86 $ 865.268  Million 925 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.